Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase

Human esophageal cancer has a global impact on human health due to its high incidence and mortality. Therefore, there is an urgent need to develop new drugs to treat or prevent the prominent pathological subtype of esophageal cancer, esophageal squamous cell carcinoma (ESCC). Based upon the screenin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ning, Lu, Xuebo, Jiang, Yanan, Zhao, Lili, Wang, Donghao, Wei, Yaxing, Yu, Yin, Kim, Myoung Ok, Laster, Kyle Vaughn, Li, Xin, Yuan, Baoyin, Dong, Zigang, Liu, Kangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512399/
https://www.ncbi.nlm.nih.gov/pubmed/36082941
http://dx.doi.org/10.7554/eLife.73953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512399/
https://www.ncbi.nlm.nih.gov/pubmed/36082941
http://dx.doi.org/10.7554/eLife.73953

Ejemplares similares